DDO-7263

N/A

Report date: 2022/01/05 15:24:33
NME

Base Information

Drug NameDDO-7263
Drug Alias NameDDO-7263
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNuclear factor erythroid 2-related factor 2 stimulants
TargetsNuclear factor erythroid 2-related factor 2
Therapy Area/IndicationsParkinson DiseaseChemical and Drug Induced Liver Injury
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesChina Pharmaceutical University
China Registration ClassN/A

Develop Information

Active CompaniesChina Pharmaceutical University
Inactive CompaniesN/A
Active IndicationsParkinson DiseaseChemical and Drug Induced Liver Injury
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A